Field of Interest: Infectious diseases

Panel calls new hepatitis C drug ‘low value’

A panel of California medical experts says two new, once-daily drugs for hepatitis C represent low-value treatment alternatives for the condition because of their high price tags. The drugs, Gilead...

Field of Interest: Infectious diseases
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness